Search

Your search keyword '"Hovius JW"' showing total 858 results

Search Constraints

Start Over You searched for: "Hovius JW" Remove constraint "Hovius JW"
858 results on '"Hovius JW"'

Search Results

1. Limited evidence of infection with other tick-borne pathogens in patients tested for Lyme neuroborreliosis in the Netherlands.

2. Exposure, infection and disease with the tick-borne pathogen Borrelia miyamotoi in the Netherlands and Sweden, 2007-2019.

3. Bridging the gap: Insights in the immunopathology of Lyme borreliosis.

4. Autochthonous Human Babesiosis Caused by Babesia venatorum, the Netherlands.

6. Persistent Symptoms After Lyme Disease: Clinical Characteristics, Predictors, and Classification.

7. Combining short- and long-read sequencing unveils geographically structured diversity in Borrelia miyamotoi .

8. Review of literature and clinical practice experience for the therapeutic management of Morgellons disease.

9. A comprehensive genetic map of cytokine responses in Lyme borreliosis.

10. Development of a sequence-based in silico OspA typing method for Borrelia burgdorferi sensu lato .

11. Evaluation and 1-year follow-up of patients presenting at a Lyme borreliosis expertise centre: a prospective cohort study with validated questionnaires.

12. [Cutaneous Lyme disease: not always a rash with a central clearing].

13. Genome-wide analyses in Lyme borreliosis: identification of a genetic variant associated with disease susceptibility and its immunological implications.

14. Tick-borne diseases in the North Sea region-A comprehensive overview and recommendations for diagnostics and treatment.

15. Determinants of persistent symptoms after treatment for Lyme borreliosis: a prospective observational cohort study.

16. Clinical manifestations of Lyme neuroborreliosis in children: a review.

17. Age-related changes in plasma biomarkers and their association with mortality in COVID-19.

18. Mapping the human genetic architecture of COVID-19

19. Gender differences in the use of cardiovascular interventions in HIV‐positive persons; the D:A:D Study

21. [New infectious diseases in Europe; the effect of climate change, globalisation and human behaviour].

22. Detection of Borrelia burgdorferi sensu lato DNA in cerebrospinal fluid samples following pre-enrichment culture.

23. Corrections to "Prevalence of persistent symptoms after treatment for lyme borreliosis: a prospective observational cohort study" [The Lancet Regional Health - Europe 6 (2021) 100142].

24. Diagnostic performance of the ZEUS Borrelia VlsE1/pepC10 assay in European LB patients: a case-control study.

25. Persistent Borrelia burgdorferi Sensu Lato Infection after Antibiotic Treatment: Systematic Overview and Appraisal of the Current Evidence from Experimental Animal Models.

26. Development and Validation of a Protein Array for Detection of Antibodies against the Tick-Borne Pathogen Borrelia miyamotoi.

27. Digital disparities among healthcare workers in typing speed between generations, genders, and medical specialties: cross sectional study.

28. Identification of novel conserved Ixodes vaccine candidates; a promising role for non-secreted salivary gland proteins.

29. Acute facial nerve palsy in children in a Lyme disease-endemic area in the Netherlands.

30. CD55 Facilitates Immune Evasion by Borrelia crocidurae, an Agent of Relapsing Fever.

31. Identifying platelet-derived factors as amplifiers of B. burgdorferi-induced cytokine production.

32. Prevalence and clinical manifestation of Borrelia miyamotoi in Ixodes ticks and humans in the northern hemisphere: a systematic review and meta-analysis.

33. Diagnostic parameters of cellular tests for Lyme borreliosis in Europe (VICTORY study): a case-control study.

34. Knowing the entire story - a focus group study on patient experiences with chronic Lyme-associated symptoms (chronic Lyme disease).

35. An intervention in general practice to improve the management of Lyme borreliosis in Denmark.

37. Self-reported symptoms and health complaints associated with exposure to Ixodes ricinus-borne pathogens.

38. Borrelia burgdorferi Is a Poor Inducer of Gamma Interferon: Amplification Induced by Interleukin-12.

39. No molecular detection of tick-borne pathogens in the blood of patients with erythema migrans in Belgium.

40. Opinion: Methodological Shortcomings in the Study on a Prophage-based PCR Test for Lyme Borreliosis.

42. Are other tick-borne infections overlooked in patients investigated for Lyme neuroborreliosis? A large retrospective study from South-eastern Sweden.

43. Probing an Ixodes ricinus salivary gland yeast surface display with tick-exposed human sera to identify novel candidates for an anti-tick vaccine.

44. Primary cutaneous melioidosis acquired in Nepal - Case report and literature review.

45. Borrelia burgdorferi sensu lato seroconversion after intravenous immunoglobulin treatment: A cohort study.

46. Diagnostic Performance of the Novel BioPlex Lyme Serological Assays in European Patients with Lyme Disease.

47. Identification and Characterization of Immunodominant Proteins from Tick Tissue Extracts Inducing a Protective Immune Response against Ixodes ricinus in Cattle.

48. Cumulative and current exposure to potentially nephrotoxic antiretrovirals and development of chronic kidney disease in HIV-positive individuals with a normal baseline estimated glomerular filtration rate: a prospective international cohort study

49. Ticking on Pandora's box: a prospective case-control study into 'other' tick-borne diseases.

50. Prevalence of persistent symptoms after treatment for lyme borreliosis: A prospective observational cohort study.

Catalog

Books, media, physical & digital resources